RADIUM-223 CHLORIDE (ALPHARADIN) IMPACT ON OVERALL SURVIVAL AND SKELETAL-RELATED EVENTS IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER WITH BONE METASTASES: A PHASE III RANDOMIZED TRIAL (ALSYMPCA)

Autoria(s): Sartor, O.; Heinrich, D.; Helle, S.I.; O'Sullivan, Joe; Chodacki, A.; Demkow, T.; Logue, J.; Seke, M.; Widmark, A.; Johannessen, D.C.; Nilsson, S.; Hoskin, P.; Solberg, A.; James, N.D.; Syndikus, I.; Vogelzang, N.; O'Bryan-Tear, C.G.; Garcia-Vargas, J.; Shan, M.H.; Parker, C.
Data(s)

01/05/2012
Identificador

http://pure.qub.ac.uk/portal/en/publications/radium223-chloride-alpharadin-impact-on-overall-survival-and-skeletalrelated-events-in-patients-with-castrationresistant-prostate-cancer-with-bone-metastases-a-phase-iii-randomized-trial-alsympca(f1505491-3825-4c7f-b035-7273b9d22ab9).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Sartor , O , Heinrich , D , Helle , S I , O'Sullivan , J , Chodacki , A , Demkow , T , Logue , J , Seke , M , Widmark , A , Johannessen , D C , Nilsson , S , Hoskin , P , Solberg , A , James , N D , Syndikus , I , Vogelzang , N , O'Bryan-Tear , C G , Garcia-Vargas , J , Shan , M H & Parker , C 2012 , ' RADIUM-223 CHLORIDE (ALPHARADIN) IMPACT ON OVERALL SURVIVAL AND SKELETAL-RELATED EVENTS IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER WITH BONE METASTASES: A PHASE III RANDOMIZED TRIAL (ALSYMPCA) ' Journal of Urology , vol 187 , pp. E279-E279 .
Tipo

article
Acesso ao item digital